Quoc Vo, DO
Neuromusculoskeletal Medicine & OMM · San Francisco, CANPI 1063479665
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $308 and has fallen 93.3% since, to $21 in 2022.
Across 26 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$127
- Lilly USA, LLC$87
- Novartis$71
- AbbVie$50
- Biodelivery Sciences International, Inc.$45
- Teva Pharmaceuticals USA, Inc.$27
- plus $154 from 7 others
What the payments were for
- Food & beverage$561100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 6 | $127 |
| Lilly USA, LLC | 4 | $87 |
| Novartis | 3 | $71 |
| AbbVie | 2 | $50 |
| Biodelivery Sciences International, Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Boston Scientific | 1 | $27 |
| Amgen | 1 | $25 |
| Neuronetics, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
How this compares
$561 in reported general payments places this provider in the 65th percentile of 113 neuromusculoskeletal medicine & omm providers in California.
See all neuromusculoskeletal medicine & omm providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuromusculoskeletal medicine & omm in San Francisco
- Raffy MirzayanBaldwin Park$458K
- Dean MatsudaLos Angeles$452K
- Scott ShoemakerSan Diego$49K
- Narendra GurbaniBellflower$40K
- Kiran BathFullerton$20K
- Richard DellBellflower$15K
- Emil DionysianAnaheim$14K
- Richard HartmanSanta Barbara$6K
- Neil HarnessAnaheim$4K
- William OharaSan Diego$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.